Jun 17, 2026
18 MIN READ

Wegovy Weight Loss Timeline: What Dosage Does Wegovy Start Working?

Semaglutide typically shows measurable weight loss within 4 to 8 weeks of starting treatment, with most patients experiencing appetite reduction in the first two weeks. PlexusDx compounded semaglutide injections start at $149/month with no dose-based pricing increases.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 17, 2026
18 MIN READ

wegovy weight loss timeline: what dosage does wegovy start working? — PlexusDx GLP-1 education

Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that signals your brain to reduce hunger and regulate blood sugar, with clinical trials showing average weight loss of 5% to 15% over the first three months. Understanding the realistic timeline and what to expect during your treatment journey helps set proper expectations and supports long-term adherence. PlexusDx offers compounded semaglutide injections starting at $149 per month from licensed 503A pharmacies, available across all 50 states without insurance requirements.

How Long Does Semaglutide Take to Start Working?

Most patients report the first signs of semaglutide's effects within 7 to 14 days, typically noticing reduced appetite and earlier fullness during meals. Clinical data from major trials shows measurable weight loss (typically 3% to 5% of starting body weight) becomes evident by the fourth to sixth week of consistent dosing. The medication works by activating GLP-1 receptors in your brain's appetite centers, a process that begins immediately but takes time to create noticeable behavioral and metabolic changes.

Initial weight loss in weeks one through four often reflects both medication effect and natural water-weight reduction as hunger decreases and caloric intake drops. Consistency matters significantly—taking your weekly injection on schedule and maintaining dietary awareness during this early phase amplifies the medication's effectiveness. Some patients experience minor digestive adjustment during week one or two, which typically resolves within days as your body adapts to the appetite-suppressing signals.

Semaglutide Dosing Schedule and Weight Loss Progression

Semaglutide treatment typically follows a 16-week titration schedule, starting at 0.25 mg weekly and increasing by 0.25 mg increments every four weeks until reaching a therapeutic dose of 1.0 mg to 2.4 mg weekly. During the first month at the starting dose, weight loss acceleration is usually modest (0.5 to 2 pounds weekly), but increases substantially once your dose reaches maintenance levels in weeks 12 through 16. Your dose may need to go up over time—your price won't, because PlexusDx charges a flat monthly rate regardless of which strength you're using.

By week 12 to 16, when most patients reach their target dose, weekly weight loss often accelerates to 1.5 to 3 pounds per week, with cumulative three-month losses ranging from 8% to 15% of starting weight. Research from the STEP clinical trial program showed participants on semaglutide lost an average of 14.9% of body weight over 68 weeks compared to 2.4% in the placebo group. Individual responses vary based on baseline metabolism, adherence, diet quality, and genetic factors that influence how your body's peptide pathways respond to GLP-1 signaling.

Weekly vs. Monthly Weight Loss Expectations on Semaglutide

During the dose-escalation phase (weeks 1 through 12), expect gradual weekly weight loss increases as your body adjusts and doses rise, typically ranging from 0.5 to 1.5 pounds per week. Once you reach your maintenance dose (weeks 13 onward), weekly losses often stabilize at 1 to 3 pounds per week, though some weeks may show larger drops due to water fluctuations and individual metabolism patterns. These rates assume consistent weekly injections, adherence to dietary guidance, and moderate physical activity—faster results sometimes occur with stricter caloric management or exercise increases.

Monthly tracking reveals clearer trends than daily or weekly scale watching, since semaglutide's effects build cumulatively over four-week cycles. By month one, most patients see 5% to 10% weight reduction; by month two, 10% to 15%; and by month three, 12% to 20% depending on starting weight and individual factors. PlexusDx recommends monthly weight checks and check-in calls with your healthcare provider to monitor progress, adjust expectations, and identify any side effects that might affect your treatment plan.

Genetic Testing to Personalize Your Semaglutide Results

Individual differences in semaglutide response are partly shaped by genetic variations in the genes that code for GLP-1 receptors, appetite-regulation peptides, and metabolic pathways. The PlexusDx Precision Peptide Genetic Test (a $99 add-on after your first month of treatment) analyzes key variants including GLP1R rs6923761 and GIPR rs1800437 to reveal your inherent peptide-pathway predispositions and predict which compounds may work most effectively for you. Understanding your genetic profile helps explain why some patients lose 20% of body weight while others lose 8% on the same dose—it's not a failure, it reflects your unique biology.

PlexusDx maps 14 metabolic and appetite-signaling pathways across 49 peptides and 150+ genetic insights to create a personalized treatment strategy that may include semaglutide alone, combination therapies, or protocol adjustments. Patients with certain genetic profiles show faster weight loss on semaglutide, while others achieve better results with tirzepatide or combination GLP-Squared therapy. Your genetic test results guide your PlexusDx provider in optimizing your timeline expectations and selecting the approach most likely to deliver results for your body.

What to Do if Semaglutide Results Plateau or Slow Down

Weight loss plateaus are normal and typically occur after 3 to 6 months as your body adapts to lower caloric intake and the medication's appetite-suppressing effects become your new baseline. If progress stalls despite consistent adherence, your PlexusDx provider may recommend increasing your dose within the approved range, adding aerobic or resistance exercise, or tightening dietary adherence to break through the plateau. Some patients benefit from a temporary medication pause (supervised by their provider) to reset receptor sensitivity, or they transition to tirzepatide, a dual GLP-1/GIP agonist that works through slightly different pathways and may overcome resistance.

Genetic factors influence your plateau point—patients with certain FTO rs9939609 or MC4R rs17782313 variants may plateau earlier and require dose optimization or compound switching to continue losing weight. Drinking adequate water, prioritizing protein intake, managing stress, and ensuring quality sleep all support continued weight loss momentum. PlexusDx's $99 Precision Peptide Genetic Test reveals which pathway adjustments or alternative compounds (like GLP-Squared oral or tirzepatide injection) might reignite your results if semaglutide alone plateaus.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

When will I see weight loss results after starting semaglutide?

Most patients notice reduced appetite within 7 to 14 days and measurable weight loss (3% to 5% of starting weight) by weeks 4 to 6. Significant weight loss (8% to 15%) typically appears by the end of month three as your dose reaches therapeutic levels. PlexusDx compounded semaglutide injections are available starting at $149 per month, with progress tracked via monthly telehealth check-ins.

Does a higher starting dose mean faster weight loss results?

No—semaglutide is dosed gradually (0.25 mg weekly increases every four weeks) to minimize side effects and allow your body to adapt, which actually produces better long-term outcomes than higher starting doses. Faster weight loss in the first weeks is driven more by reduced appetite and caloric intake than by dose amount. Your dose may need to go up over time, but your PlexusDx price stays at the same flat rate.

Can I expect the same weight loss timeline as Wegovy or Ozempic users?

PlexusDx compounded semaglutide contains the identical active ingredient as brand-name Wegovy and uses the same dosing schedule, so clinical timelines are comparable. Individual results still vary based on genetics, diet, exercise, and adherence. The key difference is cost—PlexusDx starts at $149 monthly with no insurance needed and HSA/FSA eligibility, often significantly less than brand-name options.

What if my semaglutide results slow down or plateau?

Plateaus are normal around 3 to 6 months and may signal the need for dose optimization, dietary adjustment, or exercise increases. Some patients benefit from switching to tirzepatide or GLP-Squared (a dual-compound approach) if semaglutide alone plateaus. PlexusDx's Precision Peptide Genetic Test ($99 add-on) identifies which alternative pathway might work better for your genetics if progress stalls.

How does the PlexusDx genetic test predict semaglutide success?

The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to GLP-1 signals and regulates appetite and metabolism. Results reveal your inherent peptide-pathway predispositions and help your PlexusDx provider predict whether semaglutide, tirzepatide, or a combination approach will deliver the fastest results for your unique biology. The test is $99 after your first month of treatment.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves